Form 4: Lam Research CFO Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report 3 March 2026 3:16 PM

Lam Research CFO Douglas R. Bettinger exercised stock options and subsequently sold a portion of the acquired common stock on March 2, 2026.

Summary

Douglas R. Bettinger, Chief Financial Officer and Executive Vice President of Lam Research Corp (LRCX), reported transactions on March 2, 2026.
Bettinger exercised employee stock options to acquire a total of 66,310 shares of common stock.
These options were exercised at prices of $59.881 for 16,620 shares, $54.057 for 37,980 shares, and $30.033 for 11,710 shares.
Concurrently, Bettinger sold 40,329 shares of common stock at a weighted average price of $230.22 per share, with individual sales ranging from $230.07 to $230.39.
Following these transactions, Bettinger's direct beneficial ownership of common stock stands at 1,054,012 shares, which includes shares subject to unvested restricted stock units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction involving the exercise of vested stock options and subsequent sale of shares, which is common for executive compensation and personal financial planning. The significant profit realized from the option exercise is a positive for the executive.

Positives

The exercise of stock options at significantly lower strike prices ($30.033, $54.057, $59.881) compared to the sale price ($230.22) indicates a substantial gain for the insider, reflecting the company's stock appreciation.
The transaction demonstrates the monetization of long-term incentive compensation, which is a standard practice for executives.

Negatives

The sale of 40,329 shares by a key executive, while common for diversification or tax planning, represents a reduction in direct equity holdings.

Future Outlook

Industry Context

Stakeholder Impact

Shareholders may view the sale as a routine event for executive compensation and diversification, with no immediate negative implications for company performance or strategy.
The transaction highlights the value of executive stock options as a component of compensation, aligning management interests with long-term shareholder value creation.

Key Dates

Date	Description
03/02/2021	First installment exercisable for 11,710 employee stock options.
03/01/2022	First installment exercisable for 16,620 employee stock options.
03/02/2022	Second installment exercisable for 11,710 employee stock options.
03/01/2023	Second installment exercisable for 16,620 employee stock options; First installment exercisable for 37,980 employee stock options.
03/02/2023	Third installment exercisable for 11,710 employee stock options.
03/01/2024	Third installment exercisable for 16,620 employee stock options; Second and third installments exercisable for 37,980 employee stock options.
03/02/2026	Date of reported transactions (exercise of options and sale of common stock).
03/02/2027	Expiration date for 11,710 employee stock options.
03/01/2028	Expiration date for 16,620 employee stock options.
03/01/2029	Expiration date for 37,980 employee stock options.

Recommendation

hold

This Form 4 reports a routine insider transaction where the CFO exercised stock options and sold a portion of the acquired shares. While the sale might be interpreted negatively by some, it's a common practice for executives to monetize vested options for diversification or tax purposes and does not inherently signal a change in the company's fundamental outlook. Investors should consider this transaction in the broader context of the company's financial performance and strategic initiatives.

Keywords

Lam Research, LRCX, Insider Trading, Form 4, Stock Options, CFO, Share Sale, Equity Transaction, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.